Inter Pharma PCL's Total Assets for the quarter that ended in Dec. 2024 was ฿3,021 Mil.
Warning Sign:
If a company builds assets at 70.7% a year, faster than its revenue growth rate of 30.6% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Inter Pharma PCL's average Total Assets Growth Rate was 11.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 35.00% per year.
During the past 5 years, the average Total Assets Growth Rate was 70.70% per year.
During the past 8 years, Inter Pharma PCL's highest 3-Year average Total Assets Growth Rate was 132.90%. The lowest was 35.00%. And the median was 92.00%.
The historical data trend for Inter Pharma PCL's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Inter Pharma PCL's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inter Pharma PCL (BKK:IP) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Inter Pharma PCL's Asset Turnover for the quarter that ended in Dec. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Inter Pharma PCL Total Assets Related Terms
Thank you for viewing the detailed overview of Inter Pharma PCL's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Inter Pharma PCL is a biopharmaceutical company. It is engaged in the import, manufacture and distribution of drug, and dietary supplement products for humans and animals. It offers products related to Wellness and Anti-aging, Aesthetics, Diagnostics, Vitamins, and other products. The company operates in three reportable segments Human healthcare, Animal Healthcare, and Hospital and clinics in Thailand. Key revenue is derived from the Human healthcare segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BKK:IP has been successfully added to your 